Yusuke Kashiwado

Hiroshima, 7308619, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Acute blood pressure responses and safety considerations in heat therapy interventions: A narrative review.

Acute blood pressure responses and safety considerations in heat therapy interventions: A narrative review.

Journal: Complementary therapies in medicine

Published: December 23, 2025

Hot spring and sauna use for improving blood lipid profiles: A systematic review and expert consensus on efficacy and recommendations.

Hot spring and sauna use for improving blood lipid profiles: A systematic review and expert consensus on efficacy and recommendations.

Journal: Complementary therapies in medicine

Published: June 10, 2025

Treatment selection in the clinical practice of systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.

Treatment selection in the clinical practice of systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.

Journal: Modern rheumatology

Published: April 02, 2024

Night-time hot spring bathing is associated with improved blood pressure control: A mobile application and paper questionnaire study.

Night-time hot spring bathing is associated with improved blood pressure control: A mobile application and paper questionnaire study.

Journal: PloS one

Published: October 23, 2023

Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan.

Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan.

Journal: Modern rheumatology

Published: May 01, 2023

Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients.

Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients.

Journal: Rheumatology (Oxford, England)

Published: April 04, 2023

Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study.

Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study.

Journal: Modern rheumatology

Published: February 18, 2022

Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.

Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.

Journal: Modern rheumatology case reports

Published: December 01, 2021

Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study.

Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study.

Journal: Arthritis research & therapy

Published: August 30, 2021

IgG4-related disease presenting as a paraneoplastic syndrome: report of two cases and literature review.

IgG4-related disease presenting as a paraneoplastic syndrome: report of two cases and literature review.

Journal: Modern rheumatology case reports

Published: March 15, 2021

Autoimmune manifestations associated with myelodysplastic syndrome predict a poor prognosis.

Autoimmune manifestations associated with myelodysplastic syndrome predict a poor prognosis.

Journal: Medicine

Published: July 01, 2020

Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.

Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.

Journal: PloS one

Published: February 15, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026